Figure 4 | Modern Pathology

Figure 4

From: Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas

Figure 4

Comparison of the number of mitoses in cancer cells per 10 high-power fields (a), the number of Ki-67-positive cancer cells (b), number of Ki-67-positive stromal/inflammatory cells (c) and the ratio of Ki-67-positive stromal and cancer cells (d) in low-grade invasive breast carcinomas with concordant vs discrepant (low- vs intermediate-/high-) risk estimations by Oncotype DX Recurrence Score (RS) and Mammostrat Prognostic Index (PI). (RS<18/PI≤0, n=58; RS≥18/PI≤0, n=33; RS≥18/PI>0, n=5 and RS<18/PI>0, n=10). NS, not significant; ***P<0.0001, Student's t-test.

Back to article page